LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
+6.47%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.15B
AUM Growth
+$1.15B
(-8.4%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-12.59%
Top 10 Holdings %
Top 10 Hldgs %
19.03%
Holding
431
New
73
Increased
185
Reduced
111
Closed
35
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$14.2M |
| 2 |
Evolent Health
EVH
|
$9.74M |
| 3 |
Royal Caribbean
RCL
|
$8.6M |
| 4 |
argenx
ARGX
|
$7.09M |
| 5 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$6.55M |
Top Sells
| 1 |
CIXX
CI Financial Corp.
CIXX
|
$27M |
| 2 |
KE Holdings
BEKE
|
$15.7M |
| 3 |
Huazhu Hotels Group
HTHT
|
$15.4M |
| 4 |
Abbott
ABT
|
$15M |
| 5 |
Pfizer
PFE
|
$14.1M |
Sector Composition
| 1 | Healthcare | 44.36% |
| 2 | Consumer Discretionary | 13.29% |
| 3 | Technology | 13.16% |
| 4 | Financials | 10.68% |
| 5 | Industrials | 6.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Thor Industries
THO
$5.79B
| $13.9M | 1.22% |
175,000
-25,000
| -13% | -$1.99M |
|
27
Incyte
INCY
$16.5B
| $13.9M | 1.21% |
192,505
-54,679
| -22% | -$3.95M |
|
28
Neurocrine Biosciences
NBIX
$13.8B
| $13.5M | 1.18% |
133,656
-3,794
| -3% | -$384K |
|
29
Chemed
CHE
$6.67B
| $13.4M | 1.17% |
25,000
| – | – |
|
30
Globe Life
GL
$11.3B
| $13.3M | 1.16% |
120,579
-14,695
| -11% | -$1.62M |
|
|
RCM
31
DELISTED
R1 RCM Inc. Common Stock
RCM
| $12M | 1.04% |
797,006
-422,139
| -35% | -$6.33M |
|
32
Glaukos
GKOS
$5.5B
| $10.5M | 0.92% |
209,938
+7,025
| +3% | +$352K |
|
|
ISEE
33
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $10.1M | 0.88% |
413,115
+177,556
| +75% | +$4.32M |
|
|
34
Evolent Health
EVH
$1.12B
| $9.74M | 0.85% |
+300,000
| New | +$9.74M |
|
35
Natera
NTRA
$23.1B
| $9.27M | 0.81% |
166,879
+85,710
| +106% | +$4.76M |
|
36
Option Care Health
OPCH
$4.65B
| $9.05M | 0.79% |
285,000
-15,000
| -5% | -$477K |
|
|
37
Royal Caribbean
RCL
$98.7B
| $8.6M | 0.75% |
+131,706
| New | +$8.6M |
|
38
Virtus Investment Partners
VRTS
$1.36B
| $8.57M | 0.75% |
45,000
-5,000
| -10% | -$952K |
|
39
CVS Health
CVS
$92.8B
| $8.33M | 0.73% |
112,134
-98,354
| -47% | -$7.31M |
|
|
ANSS
40
DELISTED
Ansys
ANSS
| $8.28M | 0.72% |
24,880
-1,060
| -4% | -$353K |
|
41
Medifast
MED
$154M
| $7.78M | 0.68% |
75,000
-75,400
| -50% | -$7.82M |
|
42
NVIDIA
NVDA
$4.24T
| $7.7M | 0.67% |
27,723
-2,180
| -7% | -$606K |
|
|
PRVB
43
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $7.59M | 0.66% |
314,862
-8,033
| -2% | -$194K |
|
44
American Water Works
AWK
$28B
| $7.56M | 0.66% |
51,615
+9,883
| +24% | +$1.45M |
|
45
Exact Sciences
EXAS
$8.98B
| $7.33M | 0.64% |
108,057
+21,243
| +24% | +$1.44M |
|
46
Amazon
AMZN
$2.44T
| $7.22M | 0.63% |
69,938
+13,676
| +24% | +$1.41M |
|
|
47
argenx
ARGX
$43.6B
| $7.09M | 0.62% |
+19,026
| New | +$7.09M |
|
48
Republic Services
RSG
$73B
| $6.94M | 0.61% |
51,298
+26,299
| +105% | +$3.56M |
|
49
Ventas
VTR
$30.9B
| $6.72M | 0.59% |
154,932
+150,000
| +3,041% | +$6.5M |
|
50
United Rentals
URI
$61.5B
| $6.67M | 0.58% |
16,845
-855
| -5% | -$338K |
|